CClinicalTrials.gg
Not yet recruitingNCT07405281Updated Feb 12, 2026

the Efficacy of Hyperbaric Oxygen on Acute Ankle Sprain

An interventional study of hyperbaric oxygen therapy and non Hyperbaric Oxygen Therapy in Ankle Sprain, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
208
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Investigators recruited 208 patients with acute ankle sprain who were from the Rehabilitation Department of the Second Affiliated Hospital of Zhejiang University, School of Medicine from January 2026 to November 2028. Perform the improvement in AOFAS scores and Baird-Jackson ankle scores study and Rehabilitation assessments followed up after 3 years.

Read the detailed description

In baseline, 208 patients with i acute ankle sprain were recruited from the Rehabilitation Department of the Second Affiliated Hospital of Zhejiang University School of Medicine from January 2026 to December 2028, and were followed up after 3 years.

Perform the improvement in AOFAS scores and Baird-Jackson ankle scores study and Rehabilitation assessments followed up after 3 years. The Hyperbaric oxygen group treatment was administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation. Oxygen was inhaled for 40 minutes (20 minutes of oxygen inhalation, 5-minute rest, 20 minutes of oxygen inhalation, decompression), once daily for 14 consecutive days. The control group treatment at an atmospheric pressure of 1.4 ATA, inhaling 21% oxygen by volume. Oxygen inhalation schedule: 40 minutes (inhale oxygen for 20 minutes, rest for 5 minutes, inhale oxygen for 20 minutes, decompression), once a day for 14 consecutive days.

Two person analyzed the above data, and record abnormal results.

02

Conditions studied

  • Ankle Sprain

Browse trials for

Keywords

  • acute ankle sprain
  • hyperbaric oxygen
03

In context

Ankle Injuries

352 studies on the registry are indexed under Ankle Injuries; 72 are open to participants now.

This study's planned enrollment of 208 is above the median of 56 across 273 interventional studies indexed under Ankle Injuries.

Browse Ankle Injuries studies →

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Unilateral ankle sprain;
  • Swelling, bruising, and pain at the site of the sprain;
  • Injury occurring within 72 hours;
  • MRI examination clearly shows ligament damage.

Exclusion criteria

Exclusion Criteria:

  • X-ray shows ankle fracture;
  • Ankle has skin lesions or skin diseases;
  • History of lower limb and pelvic surgery;
  • Obvious neurological or psychiatric disorders that may interfere with assessment;
  • Severe ligament injuries or joint instability requiring surgical treatment;
  • Previous ankle injuries, persistent pain or functional limitations;
  • Pneumothorax, severe emphysema, active bleeding, or other diseases with contraindications for hyperbaric oxygen therapy.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
208 participants (estimated)

Study arms

  • Experimental
    hyperbaric oxygen group

    The treatment is administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation.

    Other: hyperbaric oxygen therapy

  • Sham comparator
    non hyperbaric oxygen group

    The treatment is administered at an atmospheric pressure of 1.4 ATA with an inhaled oxygen fraction of 21%

    Other: non Hyperbaric Oxygen Therapy

Interventions

  • Otherhyperbaric oxygen therapy

    The treatment is administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation. Oxygen inhalation time: 40 minutes (inhaling oxygen for 20 minutes, resting for 5 minutes, inhaling oxygen for 20 minutes, decompression), once daily, for 14 consecutive days. (Commenced immediately after randomisation)

  • Othernon Hyperbaric Oxygen Therapy

    The treatment is administered at an atmospheric pressure of 1.4 ATA with an inhaled oxygen fraction of 21%, oxygen inhalation time: 40 minutes (20 minutes of oxygen inhalation, 5 minutes rest, 20 minutes of oxygen inhalation, decompression), once daily, for 14 consecutive days. (Commences immediately after randomisation)

06

What researchers measure

Primary outcomes

  1. AOFAS score

    Improvement of American Orthopaedic Foot \& Ankle Society Score (AOFAS scores)in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100, higher scores mean a better outcome.

    Time frame: 3 years

  2. Baird-Jackson ankle score

    Improvement of Baird-Jackson Ankle Evaluation Score(Baird-Jackson ankle scores) in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100., higher scores mean a better outcome.

    Time frame: 3 years

Secondary outcomes

  1. pain scores

    The effects of hyperbaric oxygen on improvements in pain scores Visual Analog Scale (VAS) (resting VAS and walking VAS) in patients with acute ankle sprain. Usually scored from 0 to 10. higher scores mean a worth outcome.

    Time frame: 3 years

  2. ankle swelling

    Measure the ankle joint circumference at the level of the medial malleolus tip, in millimeters, on both the affected and healthy sides, and calculate the degree of swelling. The more swollen the joints, the worth the outcome.

    Time frame: 3 years

  3. high-frequency ultrasound findings

    Observe the damage and healing of ligaments and surrounding tissues. The better the continuity of the ligaments and surrounding tissues, the better the outcome.

    Time frame: 3 years

  4. Ankle MRI

    Observe the damage and healing of ligaments and surrounding tissues. The higher the MRI signal, the worse the outcome.

    Time frame: 3 years

  5. patient's overall evaluation of treatment (PGIC)

    The doctor asks the patient about their overall feeling regarding the treatment: 'Has there been any improvement?' Choose one as your answer: Number 1 indicates significant improvement; Number 2 indicates slight improvement; Number 3 indicates no change; Number 4 indicates worsening due to the treatment. higher scores mean a worth outcome.

    Time frame: 3 years

  6. HAMA scale score

    the effects of hyperbaric oxygen on change in Hamilton Anxiety Scale(HAMA scale score)in patients with acute ankle sprain. Each item is rated on a five-point scale from 0 to 4. The total score reflects the overall severity of anxiety and can be used to assess treatment effects and changes in the condition. Total score ≥29: Possible severe anxiety. Total score ≥21: Definitely significant anxiety. Total score ≥14: Definitely anxiety. Total score ≥7: Possible anxiety. Total score \<7: No anxiety symptoms. higher scores mean a worse outcome.

    Time frame: 3 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07405281
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible party
Sponsor
First posted
Feb 12, 2026
Start date
Mar 2026 (estimated)
Primary completion
Mar 2029 (estimated)
Completion
Mar 2029 (estimated)
Last update
Feb 12, 2026

Study contacts

Bing Xiong, MD
Contact
2202030@zju.edu.cn
86-13516803156
Bing Xiong
principal investigator · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion